Gary Middleton

The Royal Surrey County Hospital
Egerton Road
Guildford
GU2 7XX
United Kingdom

CRUKE/10/025: VIP: A prospective phase II controlled multicentre randomised clinical trial comparing combined gemcitabine and vandetanib therapy with gemcitabine therapy in advanced pancreatic cancer

Feasibility Study Project Grants
Funding period: 01 September 2010 to 31 March 2013

CRUK/06/008: TeloVac: prospective, phase III, controlled, multicentre, randomised trial comparing combination Gemcitabine & Capecitabine therapy with concurrent & sequential chemoimmunotherapy using a telomerase vaccine

Phase III Clinical Trial Grants
Funding period: 01 January 2012 to 31 December 2014

Gary Middleton

Gary Middleton other research projects